Award recordCONTRACT

TAKEDA PHARMACEUTICALS AMERICA, INC.

PIID 36C26025F0052· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2025· $254,109 net obligations· UEI ENNFDLWFC6L1· MA

Description

ICLUSIG BULK ORDER - INCREASE FOR 2025 PRICING MINUS 2 DELIVERIES

Base award description: ICLUSIG BULK ORDER

First action · last action
2024-10-08 · 2026-01-15
Transactions
4
First transaction's obligation
$334,961
Base + all options value (sum of deltas)
$254,109
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79718D0586
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 4 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$339,775$0Base award · 2024-10-08 · this action $334,961 · running total $334,961Modification P00001 · 2025-01-06 · this action $4,813 · running total $339,775Modification P00002 · 2025-01-06 · this action -$481 · running total $339,293Modification P00003 · 2026-01-15 · this action -$85,184 · running total $254,109
  • Base2024-10-08+$334,961= $334,961
  • Mod P000012025-01-06+$4,813= $339,775
  • Mod P000022025-01-06-$481= $339,293
  • Mod P000032026-01-15-$85,184= $254,109
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-10-08+$334,961$334,961ICLUSIG BULK ORDER
Mod P00001· FUNDING ONLY ACTION2025-01-06+$4,813$339,775ICLUSIG BULK ORDER - INCREASE FOR 2025 PRICING
Mod P00002· FUNDING ONLY ACTION2025-01-06−$481$339,293ICLUSIG BULK ORDER - INCREASE FOR 2025 PRICING MINUS 2 DELIVERIES
Mod P00003· FUNDING ONLY ACTION2026-01-15−$85,184$254,109ICLUSIG BULK ORDER - INCREASE FOR 2025 PRICING MINUS 2 DELIVERIES

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI ENNFDLWFC6L1)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0839245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$38,360FY2026
36C24526N0825245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$38,098FY2026
36C24526N0787245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$38,098FY2026
36C24526N0772245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$34,605FY2026
36C24526N0758245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$38,098FY2026
36C24526N0712245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$14,386FY2026

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26025F0052_3600_36F79718D0586_3600 · retrieved 2026-09-26.